GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData

Following the news that the FDA has approved Argenx’s subcutaneous formulation of efgartimod alfa, branded as Vyvgart Hytrulo, for use in myasthenia gravis (MG); Barbora Salcman, Neurology Analyst at GlobalData, offers her view: “The approval comes after a period of uncertainty and extends the availability of Vyvgart to acetylcholine receptor autoantibody positive (AChR+) patients diagnosed […]
Read more

VC investment in India tumbles 74.6% YoY to $3.4 billion during January-May 2023, reveals GlobalData

India’s venture capital (VC) funding landscape faced a harsh funding winter during the first five months of 2023, witnessing a substantial 46.1% year-on-year (YoY) drop in VC deals volume and a massive 74.6% decline in funding value during the period, reflecting the challenging funding environment, according to GlobalData, a leading data and analytics company. An […]
Read more

Healthcare professionals see biosimilars as solution to tackle rising costs, finds GlobalData survey

The healthcare industry continues to face the challenges such as persistent inflation in a post-COVID-19 world. Healthcare professionals (HCPs) believe that biosimilars could provide costs savings for the patients and healthcare systems and their use should be encouraged, according to a survey by  GlobalData, a leading data and analytics company. GlobalData survey, “The Impact of […]
Read more

China venture capital funding sees decline, yet remains a force in global market, reveals GlobalData

The China venture capital (VC) funding landscape experienced a decline in both deal volume and value during January to May 2023 compared to the previous year, attributed to geopolitical tensions and recession concerns. However, China remains a dominant player in the Asia-Pacific (APAC) region and globally, showcasing its continued significance in VC funding activities, reveals […]
Read more

Consumer interest in health drives growth of functional mushroom ingredients across FMCG industry, reveals GlobalData

Consumer interest in functional mushrooms is rapidly surging as people recognize their potential health benefits. This trend is driving the growth of mushroom-infused products across FMCG industry, from food and beverages to dietary supplements and beauty, as consumers increasingly seek natural and affordable options to support their well-being, reveals GlobalData, a leading data and analytics […]
Read more

VALUE-Dx initiative highlights potential for improved respiratory infection diagnostics to decelerate AMR, says GlobalData

VALUE-Dx, a first-of-its-kind Innovative Medicines Initiative (IMI) project which aims to improve the use of antibiotics in community care settings, has recently released preliminary information from its upcoming consensus statement on rapid diagnostic tests (RDT) for acute respiratory tract infections (ARTIs) at a post- European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference. The […]
Read more

Apple Vision Pro headset sparks mixed reactions on Reddit over high price, gaming limitations, reveals GlobalData

Apple’s Vision Pro, the mixed-reality headset unveiled at the June 2023 Worldwide Developers Conference, has created a substantial buzz in the tech industry. This excitement translated into a notable increase in Reddit discussions during the second week of June. Among Redditors, there is a divergence of opinions regarding the device. While some are enamored with […]
Read more
1 … 101 102 103 104 105 … 209